Literature DB >> 24081806

Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.

Xiang-Song Wu1, Liu-Bin Shi, Mao-Lan Li, Qian Ding, Hao Weng, Wen-Guang Wu, Yang Cao, Run-Fa Bao, Yi-Jun Shu, Qi-Chen Ding, Jia-Sheng Mu, Jun Gu, Ping Dong, Ying-Bin Liu.   

Abstract

BACKGROUND: Survival after surgery for gallbladder cancer is generally poor. A number of inflammation-based prognostic scores have been established to help predict survival after surgery for several types of cancer. The objective of this study was to analyze and compare the utility of two inflammation-based prognostic scores, the Glasgow prognostic score (GPS) and the neutrophil-to-lymphocyte ratio (NLR), for predicting survival in patients with gallbladder cancer after surgery with curative intent.
METHODS: We retrospectively reviewed the medical records of 85 patients with histologically confirmed, resectable gallbladder carcinoma (GBC), who were to receive curative surgery in our department. Univariate and multivariate analyses were performed to evaluate the relationship between the variables to overall survival (OS).
RESULTS: A significant difference was detected in OS in patients with low and high GPS and NLR scores. Univariate analyses using clinicopathological characteristics revealed that tumor differentiation; tumor invasion; lymph node metastasis; tumor, node, metastasis classification system stage; positive margin status; combined common bile duct resection; serum levels of C-reactive protein, albumin, carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen, and CA125; white blood cell count; and GPS and NLR were all associated with OS. Among these characteristics, multivariate analysis demonstrated that a high GPS was independently associated with poorer OS, together with tumor invasion, lymph node metastasis, and positive margin status.
CONCLUSIONS: GPS is superior to NLR with respect to its prognostic value for patients with GBC after surgery with curative intent. GPS is not only associated with tumor progression but is also an independent marker of poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24081806     DOI: 10.1245/s10434-013-3292-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  46 in total

1.  The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection.

Authors:  Akira Iwaku; Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Hirokazu Nishino; Masato Matsushima; Hisao Tajiri
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

2.  Preoperative C-Reactive Protein/Albumin Ratio as a Predictive Factor for Gallbladder Carcinoma.

Authors:  Masashi Utsumi; Hideki Aoki; Seichi Nagahisa; Seitaro Nishimura; Yuta Une; Yuji Kimura; Megumi Watanabe; Fumitaka Taniguchi; Takashi Arata; Koh Katsuda; Kohji Tanakaya
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.

Authors:  Kai Lu; Feiling Feng; Yingcheng Yang; Kai Liu; Jicheng Duan; Hu Liu; Jiahe Yang; Mengchao Wu; Chen Liu; Yanxin Chang
Journal:  J Gastroenterol       Date:  2019-09-27       Impact factor: 7.527

4.  Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.

Authors:  Lingqiang Zhang; Ruitao Wang; Wei Chen; Xinsen Xu; Shunbing Dong; Haining Fan; Chang Liu
Journal:  HPB (Oxford)       Date:  2016-05-06       Impact factor: 3.647

5.  Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.

Authors:  Jing-Hui Du; Jun Lu
Journal:  J Clin Lab Anal       Date:  2018-11-21       Impact factor: 2.352

6.  Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.

Authors:  Y Zhang; C Jiang; J Li; J Sun; X Qu
Journal:  Clin Transl Oncol       Date:  2015-06-16       Impact factor: 3.405

7.  Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.

Authors:  Qing Pang; Ling-Qiang Zhang; Rui-Tao Wang; Jian-Bin Bi; Jing-Yao Zhang; Kai Qu; Su-Shun Liu; Si-Dong Song; Xin-Sen Xu; Zhi-Xin Wang; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

8.  MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway.

Authors:  Xiang-Song Wu; Xu-An Wang; Wen-Guang Wu; Yun-Ping Hu; Mao-Lan Li; Qian Ding; Hao Weng; Yi-Jun Shu; Tian-Yu Liu; Lin Jiang; Yang Cao; Run-Fa Bao; Jia-Sheng Mu; Zhu-Jun Tan; Feng Tao; Ying-Bin Liu
Journal:  Cancer Biol Ther       Date:  2014-03-21       Impact factor: 4.742

9.  Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion.

Authors:  Yong Wang; Qiang Hong; Jianjun Wang; Yuejun Fang; Conggang Hu
Journal:  Tumour Biol       Date:  2014-01-15

Review 10.  Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.

Authors:  Yun-Feng Wang; Fei-Ling Feng; Xu-Hong Zhao; Zhen-Xiong Ye; He-Ping Zeng; Zhen Li; Xiao-Qing Jiang; Zhi-Hai Peng
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.